NX-13 treatment - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

AbbVie wraps up strategic acquisition of Landos Biopharma for $137.5 million to enhance its immunology portfolio and promises advancements in IBD treatment.

Read More

2 minute read

Pharma Industry News

AbbVie completes acquisition of Landos Biopharma to strengthen immunology portfolio

AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has announced the completion of its acquisition of Landos Biopharma,…

byPallavi Madhiraju

May 25, 2024

web analytics